Skip to content
RDL Network logo
The incidence of serious bleeding events in a global, single-arm, open-label trial of Drotrecogin alfa (activated) in adult patients with severe sepsis (ENHANCE): comparisons with PROWESS — Rupert Beale (2004) | RDL Network